Hide Board Information

Show Board Information

BioXcel Therapeutics Inc. BTAI

Board Mod: Add me as mod

Asst Mods:

Last Post: 08/04/2025 3:36:07 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

BioXcel Therapeutics Inc. (NASDAQ: BTAI) Stock Message Board

1. BTAI Company Profile

    

2. BTAI Time & Sales

    

3. BTAI Recent News

    

4. BTAI Filings

    

5. BTAI Financials

    

6. BTAI Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

8	$BTAI H2.58 RL1.3 :LL1.17 F6.056M up	znewcar1	08/04/2025 3:36:07 PM
7	$BTAI Hod2.4 F6.056M RL1.3	znewcar1	08/04/2025 2:19:27 PM
6	$BTAI ML2.42 RL2.6 Hod2.99	znewcar1	03/14/2024 2:07:13 PM
5	$BTAI 31% v13,4M c3.99 f29,267M Hod4.20 ML2.23	znewcar1	10/30/2023 10:23:53 PM
4	BTAI 55% v4,6M c36.97 f18M preMH@43 S@32 HOD@40	znewcar1	02/14/2020 10:16:54 PM
3	BTAI 26% v1,6M c23.85 f18M H25.04	znewcar1	02/14/2020 12:19:39 AM
2	BTAI 22% v1,9M c16.71 f18M H19.89	znewcar1	01/03/2020 4:52:25 PM
1	2018-1227 +80.91% v2,714,733 c4.36 f15,645,545	znewcar1	01/19/2019 3:02:05 PM

Recent Articles

• Breakthrough Outcomes of Telitacicept in Sjögren's Syndrome Study
• Republic Power Group's Initial Public Offering Unveiled
• Publicis Groupe Shows Impressive 5.7% Organic Growth in Q3 2025
• Serabi Gold Celebrates Record Production of Gold Ounces
• Publicis Groupe Reports Impressive Third Quarter Growth
• Ericsson and Vodafone Unveil Ambitious Network Partnership
• Transforming Connectivity: Ericsson and Vodafone's Bold Partnership
• ASUS Launches Revolutionary AI Solutions for Enterprises
• Moomoo Emerges as Australia's Leading Trading App in Downloads
• Leqembi Iqlik Recognized as a Leading Innovation of 2025
• Leqembi Iqlik™ Recognized as a Top Medical Innovation of 2025
• Arcadis Shares Buyback Initiatives Drive Corporate Strategy
• WISeKey Reports Strong Revenue Growth and Future Prospects
• DNO ASA's Q3 2025 Update: Production and Financial Insights
• dsm-firmenich Sees Steady Progress in Share Buyback Program
• Memecoin Surge: Shiba Inu and Pepe Lead the Charge
• ASUS Leads in AI Solutions with Innovative NVIDIA Technologies
• DHT Holdings, Inc. Provides Insight into Financial Progress
• How the Crypto Market is Impacting Gold Prices Today
• Apple's iPhone Air Preorders Begin as eSIM Services Launch
• Lodha's Recognition as a Trusted Company Escalates Its Prestige
• Lodha's Achievement in Global Trust Recognition Highlights Values
• Howard Marks Analyzes Current Market Valuations and Trends
• ADI Foundation's Bold Mission: Bridging Global Digital Gaps
• BenQ's New Monitors Enhance Creativity for Mac Users
• U.S. Lumber Coalition Celebrates Trade Law Enforcement Gains
• Airties Launches Nova: A New Era for Connectivity Testing
• Dr. James Petros Unveils OrthoGen Health: A New Era in Healing
• Marketing Maven Secures Spot Among Nation's Elite PR Agencies
• Vacca Family Law Group Enhances Support for Peaceful Divorce
• Dow Inc. Investors Urged to Act in Upcoming Securities Case
• Adlai Nortye to Showcase Innovative Cancer Therapy at Key Conference
• Understanding Shareholder Rights and Legal Options for Investors
• Investigation Into Shareholder Rights for Companies in Transition
• Adlai Nortye's Pioneering Cancer Therapy Presentation at Key Conference
• How Google's AI Insights Are Shaping the Future of Search
• GOL Linhas Aéreas Merges with Gol Investment Brasil for Growth
• Market Update: Ethereum and XRP Shine While Bitcoin Consolidates
• Steve Eisman Highlights Growing Economic Disconnect in America
• CoHNA Celebrates Governor's Decision Against SB509 Bill
• Forecasting Growth of Anesthesia Management Systems Until 2034
• Valuable Life Lessons From Donald Trump to His Granddaughter
• GIGABYTE Unveils Global Availability of AI TOP ATOM Supercomputer
• ASUS Unveils the Game-Changing Ascent GX10 AI Supercomputer
• Apollomics, Inc. Embraces New Leadership to Advance Oncology
• Spyre Therapeutics Focuses on $275 Million Common Stock Offering
• Spyre Therapeutics Secures Funding for Advanced Therapeutics
• Take Action: Join the Quanex Building Products Class Action
• Jasper Therapeutics Investors Invited to Join Class Action Suit
• Cytokinetics, Inc. Investors: Important Class Action Alert